| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Lisa McClain MI09 | 2 | 1 | +$8.0K | Sold Aug 13, 25 |
| Gilbert Cisneros CA31 | 2 | 1 | +$8.0K | Bought Aug 5, 25 |
| Rob Bresnahan PA08 | 2 | −$40.5K | Sold May 15, 25 | |
| Jefferson Shreve IN06 | 1 | 1 | +$0 | Sold May 12, 25 |
| Dan Newhouse WA04 | 1 | −$8.0K | Trimmed Apr 11, 25 | |
| Jared Moskowitz FL23 | 3 | −$24.0K | Sold Mar 10, 25 | |
| Valerie Hoyle OR04 | 1 | 1 | +$0 | Sold Jan 13, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Aug 13, 25 | Lisa McClain MI09 | Spouse | Sell | $1,001 - $15,000 | Sep 12, 25 (30d) | |
| Aug 5, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Sep 12, 25 (38d) | |
| Jul 10, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Aug 13, 25 (34d) | |
| Jun 24, 25 | Lisa McClain MI09 | Spouse | Buy | $1,001 - $15,000 | Aug 13, 25 (50d) | |
| May 30, 25 | Gilbert Cisneros CA31 | Self | Sell | $1,001 - $15,000 | Jun 6, 25 (7d) | |
| May 15, 25 | Rob Bresnahan PA08 | Self | Sell | $15,001 - $50,000 | May 31, 25 (16d) | |
| May 12, 25 | Jefferson Shreve IN06 | Self | Sell | $15,001 - $50,000 | Jun 22, 25 (41d) | |
| Apr 29, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | May 6, 25 (7d) | |
| Apr 11, 25 | Dan Newhouse WA04 | Spouse | Sell (part) | $1,001 - $15,000 | May 16, 25 (35d) | |
| Mar 10, 25 | Jared Moskowitz FL23 | Child | Sell | $1,001 - $15,000 | Apr 8, 25 (29d) | |
| Mar 10, 25 | Jared Moskowitz FL23 | Child | Sell | $1,001 - $15,000 | Apr 8, 25 (29d) | |
| Mar 10, 25 | Jared Moskowitz FL23 | Self | Sell | $1,001 - $15,000 | Apr 8, 25 (29d) | |
| Feb 24, 25 | Jefferson Shreve IN06 | Self | Buy | $15,001 - $50,000 | Mar 9, 25 (13d) | |
| Jan 13, 25 | Valerie Hoyle OR04 | Spouse | Sell | $1,001 - $15,000 | Sep 12, 25 (242d) | |
| Jan 13, 25 | Rob Bresnahan PA08 | Joint | Sell | $1,001 - $15,000 | Feb 13, 25 (31d) | |
| Oct 29, 24 | Valerie Hoyle OR04 | Spouse | Buy | $1,001 - $15,000 | Sep 12, 25 (318d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Kaye MarkChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Jul 16, 2026 | Boudreaux Gail A KoziaraChief Executive Officer | Purchase at price 366.41 - 368.25 per share. | 2.7K | $1.00M |
| Jul 16, 2026 | Peru Ramiro GDirector | Purchase at price 366.05 per share. | 1K | $366.05K |
| Jun 11, 2026 | Penczek Ronald WOfficer | Sale at price 403.16 per share. | 369 | $148.77K |
| Jun 10, 2026 | Dixon Robert L JrDirector | Sale at price 401.77 per share. | 151 | $60.67K |
| May 18, 2026 | Penczek Ronald WOfficer | Sale at price 403.13 per share. | 1.5K | $617.19K |
| May 18, 2026 | Penczek Ronald WOfficer | Conversion of Exercise of derivative security at price 271.27 - 311.48 per share. | 1.5K | $450.58K |
| May 12, 2026 | Jallal BahijaDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Neri Antonio FDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Devore Susan DDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Strable-Soethout Deanna DDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Schneider Ryan M.Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Collis Steven HowardDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Schulman Amy W.Director | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Dixon Robert L JrDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Peru Ramiro GDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| May 12, 2026 | Hay Lewis IiiDirector | Stock Award(Grant) at price 0.00 per share. | 563 | — |
| Mar 11, 2026 | Schulman Amy W.Director | Sale at price 287.50 per share. | 26 | $7.47K |
| Mar 5, 2026 | Kendrick Charles Morgan JrOfficer | Sale at price 284.92 per share. | 3.2K | $910.60K |
| Mar 4, 2026 | Collis Steven HowardDirector | Purchase at price 289.84 per share. | 3K | $869.52K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.4 | -7.4 | -8.5 | 28.6 | 4.5 | -1.6 | -2.8 | 4.4 | -0.9 | 8.6 | +20.4% | ||
| 2025 | 7.3 | 0.3 | 9.6 | -3.3 | -8.7 | 1.3 | -27.2 | 12.6 | 1.4 | -1.8 | 6.6 | 3.6 | −5.0% |
| 2024 | 4.6 | 1.6 | 3.4 | 1.9 | 1.9 | 0.6 | -1.8 | 4.7 | -6.6 | -22.0 | 0.3 | -9.4 | −21.8% |
| 2023 | -2.5 | -6.1 | -2.1 | 1.9 | -4.4 | -0.8 | 6.2 | -6.3 | -1.5 | 3.4 | 6.5 | -1.7 | −8.1% |
| 2022 | -4.9 | 2.5 | 8.7 | 2.2 | 1.5 | -5.3 | -1.1 | 1.7 | -6.4 | 20.4 | -2.5 | -3.7 | +10.7% |
| 2021 | -7.5 | 2.1 | 18.4 | 5.7 | 5.0 | -4.1 | 0.6 | -2.3 | -0.6 | 16.7 | -6.6 | 14.1 | +44.4% |
| 2020 | -12.2 | -3.1 | -11.7 | 23.6 | 4.8 | -10.6 | 4.1 | 2.8 | -4.6 | 1.6 | 14.2 | 3.1 | +6.3% |
| 2019 | 15.4 | -0.7 | -4.6 | -8.3 | 5.7 | 1.5 | 4.4 | -11.2 | -8.2 | 12.1 | 7.3 | 4.6 | +15.0% |
| 2018 | 10.2 | -5.0 | -6.7 | 7.4 | -6.2 | 7.5 | 6.3 | 4.6 | 3.5 | 0.6 | 5.3 | -9.5 | +16.7% |
| 2017 | 7.2 | 6.9 | 0.3 | 7.6 | 2.5 | 3.2 | -1.0 | 5.3 | -3.1 | 10.2 | 12.3 | -4.2 | +56.5% |
| 2016 | -6.4 | 0.2 | 6.4 | 1.3 | -6.1 | -0.6 | 0.0 | -4.8 | 0.2 | -2.8 | 17.0 | 0.9 | +3.1% |
| 2015 | 7.4 | 8.5 | 5.4 | -2.3 | 11.2 | -2.2 | -6.0 | -8.6 | -0.7 | -0.6 | -6.3 | 6.9 | +11.0% |
| 2014 | -6.9 | 5.3 | 9.9 | 1.1 | 7.6 | -0.7 | 2.0 | 6.1 | 2.7 | 5.9 | 1.0 | -1.8 | +36.0% |
| 2013 | 6.4 | -4.1 | 6.5 | 10.1 | 5.6 | 6.3 | 4.5 | -0.5 | -1.8 | 1.4 | 9.5 | -0.5 | +51.7% |
| 2012 | -2.9 | 2.0 | 12.4 | -8.1 | -0.6 | -5.3 | -16.5 | 12.3 | -3.1 | 5.7 | -8.8 | 9.0 | −8.0% |
| 2011 | 9.3 | 7.0 | 5.0 | 10.0 | 1.8 | 0.8 | -14.2 | -6.3 | 3.1 | 5.5 | 2.4 | -6.1 | +16.5% |
| 2010 | 9.3 | -2.9 | 4.1 | -16.4 | -4.6 | -4.6 | 3.7 | -2.1 | 14.1 | -4.1 | 2.6 | 2.0 | −2.5% |
| 2009 | -1.6 | -18.2 | 11.9 | 12.6 | 8.9 | 9.3 | 3.4 | 0.4 | -10.4 | -1.3 | 15.5 | 7.9 | +38.4% |
| 2008 | -10.9 | -10.4 | -37.0 | 12.7 | 12.2 | -14.6 | 10.1 | 0.6 | -11.4 | -16.9 | -8.4 | 18.3 | −52.0% |
| 2007 | -0.4 | 1.3 | 2.2 | -2.6 | 3.1 | -1.9 | -5.9 | 7.3 | -2.1 | 0.4 | 6.3 | 4.2 | +11.5% |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Buy / hold / sell counts